RSS | Login | Register

Delicia Honen Yard

Recent Articles

The Lowdown on HIFU: An Interview with David Y.T. Chen, MD, FACS

January 13, 2012

Although high-intensity focused ultrasound (HIFU) has not yet been approved in the United States for the treatment of prostate cancer, a growing number of the nation's urologists are offering this noninvasive surgical procedure at centers located outside the country. Renal & Urology News asked urologic oncologist David Y.T. Chen, MD, FACS, of Fox Chase Cancer Center in Philadelphia, about his impressions of HIFU as an investigator in a trial featuring the treatment.

Well-Done Ground Beef May Raise Risk of Aggressive PCa

December 05, 2011

A study of 470 cases of aggressive prostate cancer (PCa) and 512 controls demonstrated that higher consumption of any ground beef or processed meats was associated with an increased risk of aggressive PCa, particularly when the meat was grilled or barbecued and when well-done.

The Case for Neonatal Male Circumcision: An Interview with Aaron Tobian, MD, PhD

December 01, 2011

Less than a decade ago, Aaron Tobian, MD, PhD, would not have been a proponent of male circumcision. But now the benefits of this procedure are undeniable to the Johns Hopkins Center for Global Health pathologist, who has studied the matter extensively both in the United States and in Uganda. Dr. Tobian spoke with Renal & Urology News hours after returning from his most recent trip to sub-Saharan Africa.

Better Lithotripsy On the Horizon: An Interview with James E. Lingeman, MD

November 01, 2011

A leading authority on kidney stone disease, James E. Lingeman, MD, of Indiana University Health, updates Renal & Urology News on the state of urinary stone treatment, including a possible rebirth of extracorporeal shock wave lithotripsy and the pursuit of the "holy grail" in flexible ureteroscopy.

Saw Palmetto No More Effective than Placebo for BPH

October 14, 2011

Saw palmetto fruit extracts are widely used to treat lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH), but a new study shows that these extracts are no better than placebo at easing symptoms, according to investigators.

Hospitalization Risk Higher Following Prostate Biopsy

October 13, 2011

An analysis of hospital admissions from 1991 to 2007 for 17,472 men who underwent prostate biopsy and 134,977 controls revealed a 30-day hospitalization rate of 6.9% within 30 days of biopsy—substantially higher than the 2.7% in the control population.

High Serum Phosphate May Advance CKD

October 01, 2011

Those with phosphate levels in the highest two quartiles progressed significantly faster either to end-stage renal disease (ESRD) or to a composite endpoint of a doubling of serum creatinine.

PSA Testing: Why the U.S. and Europe Differ

September 21, 2011

Solid evidence for a survival benefit from PSA screening for prostate cancer is lacking, but the practice is more widespread in the United States than in many European countries.

Dialysis in the U.S. and Abroad

September 09, 2011

Four nephrologists weigh in about the substantive differences in dialysis implementation in this country and worldwide.

Persistent Hematuria in Kids Portends ESRD

September 09, 2011

End-stage renal disease (ESRD) is more likely to develop in adolescents and young adults with persistent microscopic hematuria, according to a report in the Journal of the American Medical Association (2011;306:729-736).

« Previous